In summary, these preclinical in vivo and ex vivo data strongly suggest that SDF-1/CXCR4-mediated residency of tumor cells in stem cell niches induces resistance to chemo- and/or radiation therapy probably by inducing expression of a therapy-resistant cancer stem(-like) cell phenotype. This evidence concerns the gene CXCL12 and cancer.